NCT06498492

Brief Summary

The goal of this observational study is to evaluate the outcomes of early versus delayed cholecystectomy following mild biliary pancreatitis in Nepalese patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 12, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2021

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

July 5, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 12, 2024

Completed
Last Updated

July 12, 2024

Status Verified

July 1, 2024

Enrollment Period

5 months

First QC Date

July 5, 2024

Last Update Submit

July 5, 2024

Conditions

Keywords

Biliary Acute PancreatitisLaparoscopic CholecystectomyOutcomes

Outcome Measures

Primary Outcomes (1)

  • Total duration of hospital stay among early cholecystectomy group vs delayed cholecystectomy group

    In the early group, the time interval between admission to the day of discharge following laparoscopic cholecystectomy was taken into account. In the delayed group, total duration of hospital stay in conservative management period as well as for laparoscopic cholecystectomy was taken into account.

    4 weeks

Study Arms (2)

Early cholecystectomy group

For group division patients were asked to select a paper randomly from a box, offering them the choice between early or delayed laparoscopic cholecystectomy although the ultimate decision was influenced by patient preference. Those patients whose paper came early underwent early laparoscopic cholecystectomy within index hospital.

Procedure: Laparoscopic Cholecystectomy

Late cholecystectomy group

Those patients whose paper came delayed were discharged after symptoms subside and were readmitted after 6 weeks to undergo laparoscopic cholecystectomy.

Procedure: Laparoscopic Cholecystectomy

Interventions

Laparoscopic cholecystectomy (LC) has been established as the gold standard of treatment for acute mild biliary pancreatitis.

Early cholecystectomy groupLate cholecystectomy group

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients diagnosed with acute mild biliary pancreatitis according to the Revised Atlanta classification 2012 were enrolled from the Emergency/Outpatient Department.Eligible patients were informed about treatment options (early vs. delayed LC) and provided informed written consent. Randomization into "early" or "delayed" groups was performed, and detailed investigations were conducted. To avoid bias, randomization was accomplished by lottery method. In the early group, laparoscopic cholecystectomy was performed during the same admission, while delayed group patients underwent surgery after symptom resolution and readmission.

You may qualify if:

  • Patients (\>18 years of age) who presented with the diagnosis of acute mild biliary pancreatitis in our hospital were included after obtaining written consent

You may not qualify if:

  • patients with severe sepsis, acute moderate and severe pancreatitis, immunocompromised conditions, biliary peritonitis, cholangitis, pregnancy, admission to the intensive care unit (ICU) or high dependency unit (HDU) and those who declined to provide consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ishwor Thapaliya

Kathmandu, 44600, Nepal

Location

MeSH Terms

Interventions

Cholecystectomy, Laparoscopic

Intervention Hierarchy (Ancestors)

CholecystectomyBiliary Tract Surgical ProceduresDigestive System Surgical ProceduresSurgical Procedures, OperativeLaparoscopyEndoscopyMinimally Invasive Surgical Procedures

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
4 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Mr.

Study Record Dates

First Submitted

July 5, 2024

First Posted

July 12, 2024

Study Start

September 1, 2020

Primary Completion

February 12, 2021

Study Completion

August 15, 2021

Last Updated

July 12, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

Types of IPD to be Shared: Demographic data of the participants (age, gender, comorbidities). Data on the severity of biliary pancreatitis. Surgical outcomes, including the length of hospital stay, duration of surgery, and conversion rate to open cholecystectomy. Data on recurrent biliary events and perioperative complications. Groups and Time Frame: The study divided participants into two groups: Early Cholecystectomy Group: Intervention: Underwent laparoscopic cholecystectomy within a short period after diagnosis of acute mild biliary pancreatitis. Time Frame: Mean hospital stay of 5.42 ± 1.01 days. Delayed Cholecystectomy Group: Intervention: Underwent laparoscopic cholecystectomy after an extended period following the initial diagnosis. Time Frame: Mean hospital stay of 9.36 ± 1.53 days. Data Sharing Mechanism: Data will be available upon reasonable request from the corresponding author.

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be available for a period of 1 year.
Access Criteria
Researchers must provide a clear scientific rationale for requesting the data. Data will be shared upon reasonable request to the corresponding author. Requests must detail the intended use of the data and ensure it aligns with the ethical guidelines, ensuring patient confidentiality.

Locations